Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biondvax Pharma ADR (BVXV)

Biondvax Pharma ADR (BVXV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,540
  • Shares Outstanding, K 1,868
  • Annual Sales, $ 0 K
  • Annual Income, $ -5,800 K
  • EBIT $ -8 M
  • EBITDA $ -7 M
  • 60-Month Beta 2.37
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.55
  • Most Recent Earnings $-1.11 on 08/11/23
  • Next Earnings Date 08/24/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2500 +8.80%
on 08/22/23
1.3900 -2.16%
on 08/28/23
-0.0200 (-1.45%)
since 08/04/23
3-Month
1.2500 +8.80%
on 08/22/23
1.8703 -27.28%
on 07/12/23
-0.0716 (-5.00%)
since 06/06/23
52-Week
1.2500 +8.80%
on 08/22/23
11.8000 -88.47%
on 09/22/22
-8.9000 (-86.74%)
since 09/06/22

Most Recent Stories

More News
BiondVax Pharmaceuticals (NASDAQ: BVXV) Rebrands as Scinai Immunotherapeutics Ltd.

BiondVax (NASDAQ: BVXV), a biotechnology company, today announced a change of its corporate name to Scinai Immunotherapeutics, which will debut on the Nasdaq under a new symbol, SCNI, on Sept. 7, 2023....

BVXV : 1.3600 (+3.82%)
BiondVax Pharmaceuticals (NASDAQ: BVXV) Positioned Favorably with Worldwide License to Anti-IL-17 NanoAbs

BiondVax (NASDAQ: BVXV), a biotechnology company that recently signed an exclusive worldwide license to develop and commercialize innovative alpaca-derived nanosized antibodies (“NanoAbs”) targeting...

BVXV : 1.3600 (+3.82%)
LLY : 789.12 (+0.87%)
DICE : 47.55 (+0.06%)
BiondVax Pharmaceuticals (NASDAQ: BVXV) Is Fast on the Trail to Target IL-17

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune...

BVXV : 1.3600 (+3.82%)
BiondVax Pharmaceuticals (NASDAQ: BVXV) Advances NanoAb as IL-17 Drug Candidate for Psoriasis

Modern-day medicine has been revolutionized and personalized to cater to more specific disease characteristics. A prime example of this innovation is monoclonal antibodies (“mAbs”) and nanosized antibodies...

APGE : 44.50 (+0.41%)
BVXV : 1.3600 (+3.82%)
BiondVax Pharmaceuticals (NASDAQ: BVXV) Releases Q2 Financial Report, Corporate Update

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious...

BVXV : 1.3600 (+3.82%)
BiondVax Pharmaceuticals’ (NASDAQ: BVXV) Alpaca-Derived Nanobodies for Potential Treatment of Diseases Underserved by Current Therapeutics

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious...

BVXV : 1.3600 (+3.82%)
BiondVax Pharmaceuticals (NASDAQ: BVXV) Releases Q2 Financial Report, Corporate Update

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious...

BVXV : 1.3600 (+3.82%)
BiondVax Pharmaceuticals (NASDAQ: BVXV) Granted Extension to Regain NASDAQ Compliance

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious...

BVXV : 1.3600 (+3.82%)
BiondVax (NASDAQ: BVXV) Leveraging NanoAb Pipeline to Target Large Markets

BiondVax (NASDAQ: BVXV) is an innovative biotechnology company focused on developing, manufacturing and commercializing potential blockbuster immunotherapeutic products primarily for the treatment of infectious...

BVXV : 1.3600 (+3.82%)
M&A Activity, Sales of Anti-IL-17 Drugs Suggest Upside Potential for BiondVax Pharmaceuticals (NASDAQ: BVXV)

According to Goldman Sachs Research, the global pharmaceutical industry is sitting on about $700 billion in dealmaking firepower, expected to fuel M&A-driven growth as companies look to revamp their intellectual...

BVXV : 1.3600 (+3.82%)
GS : 585.48 (-1.04%)
LLY : 789.12 (+0.87%)
DICE : 47.55 (+0.06%)

Business Summary

BiondVax Pharmaceuticals Ltd. is a biopharmaceutical company. The company's product includes Multimeric-001 universal flu vaccine which provides multi-season and multi-strain protection against human influenza virus strains. BiondVax Pharmaceuticals Ltd. is based in Ness Ziona, Israel.

See More

Key Turning Points

3rd Resistance Point 1.4300
2nd Resistance Point 1.4000
1st Resistance Point 1.3800
Last Price 1.3600
1st Support Level 1.3300
2nd Support Level 1.3000
3rd Support Level 1.2800

See More

52-Week High 11.8000
Fibonacci 61.8% 7.7699
Fibonacci 50% 6.5250
Fibonacci 38.2% 5.2801
Last Price 1.3600
52-Week Low 1.2500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar